Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Activity and Messenger Ribonucleic Acid Levels Are Associated with Adiposity and Insulinemia in Pima Indians and Caucasians
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Metabolic effects of cortisol may be critically modulated by glucocorticoid metabolism in tissues. Specifically, active cortisol is regenerated from inactive cortisone by the enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11-HSD1) in adipose and liver. We examined activity and mRNA levels of 11-HSD1 and tissue cortisol and cortisone levels in sc adipose tissue biopsies from 12 Caucasian (7 males and 5 females) and 19 Pima Indian (10 males and 9 females) nondiabetic subjects aged 28 +/- 7.6 yr (mean +/- SD; range, 18-45). Adipose 11-HSD1 activity and mRNA levels were highly correlated (r = 0.51, P = 0.003). Adipose 11-HSD1 activity was positively related to measures of total (body mass index, percentage body fat) and central (waist circumference) adiposity (P < 0.05 for all) and fasting glucose (r = 0.43, P = 0.02), insulin (r = 0.60, P = 0.0005), and insulin resistance by the homeostasis model (r = 0.70, P < 0.0001) but did not differ between sexes or ethnic groups. Intra-adipose cortisol was positively associated with fasting insulin (r = 0.37, P = 0.04) but was not significantly correlated with 11-HSD1 mRNA or activity or with other metabolic variables. In this cross-sectional study, higher adipose 11-HSD1 activity is associated with features of the metabolic syndrome. Our data support the hypothesis that increased regeneration of cortisol in adipose tissue influences metabolic sequelae of human obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This differential effect was largely related to the impact on β-cell function11,138.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
In the citing paper
“Whereas the onset of glucose lowering with the other two medications was slower, it was most sustained with rosiglitazone, with metformin demonstrating an intermediate pattern.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
In the citing paper
“Glibenclamide produced the greatest initial reduction in glycaemia, but was poorest in maintaining glucose control.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Rosmond, R., Dallman, M. F., & Björntorp, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4843 · Cited by 871
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
The role of TNFα and TNF receptors in obesity and insulin resistance
Hotamisligil, G. S. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00490.x · Cited by 780 · cited 1×
“46 Fasting insulin (mU/liter) 45 [38–52] 38 [32–51] 0.”
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Self-citationTissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655
Self-citationPhillips, D. I. W., Barker, D. J. P., Fall, C. H. D., Seckl, J. R., Whorwood, C. B., Wood, P. J., & Walker, B. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4634 · Cited by 596
Rosmond, R. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1853 · Cited by 590
Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578 · cited 1×
“46 Fasting insulin (mU/liter) 45 [38–52] 38 [32–51] 0.”
Hanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463
Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase
Agarwal, A. K., Monder, C., Eckstein, B., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47248-7 · Cited by 455
Morton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
Rask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Self-citationCortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population
Fraser, R., Ingram, M. C., Anderson, N. H., Morrison, C., Davies, E., & Connell, J. M. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1364 · Cited by 370
Obesity and Gender Influence Cortisol Secretion and Metabolism in Man
Andrew, R., Phillips, D. I. W., & Walker, B. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1806 · Cited by 360
Self-citationLivingstone, D. E. W., Jones, G. C., Smith, K., Jamieson, P. M., Andrew, R., Kenyon, C. J., & Walker, B. R. (2000) · Endocrinology · doi:10.1210/endo.141.2.7297 · Cited by 347
Self-citationPhillips, D. I. W. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.757 · Cited by 337
Jamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Obesity in the Pima Indians: its magnitude and relationship with diabetes
Knowler, W., Pettitt, D., Saad, M., Charles, M., Nelson, R., Howard, B., Bogardus, C., & Bennett, P. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.6.1543s · Cited by 286
Use of dual-energy X-ray absorptiometry in obese individuals
Tataranni, P., & Ravussin, E. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.4.730 · Cited by 250
Self-citationPaulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M.-C., & Grino, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8614 · Cited by 241
Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222
Berger, J., Tanen, M., Elbrecht, A., Hermanowski-Vosatka, A., Moller, D. E., Wright, S. D., & Thieringer, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003592200 · Cited by 208
Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
Andrews, R. C., Herlihy, O., Livingstone, D. E. W., Andrew, R., & Walker, B. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020048 · Cited by 199
Self-citationTomlinson, J. W., Sinha, B., Bujalska, I., Hewison, M., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020687 · Cited by 187
Walker, B. R., Soderberg, S., Lindahl, B., & Olsson, T. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00609.x · Cited by 151
Self-citationNapolitano, A., Voice, M. W., Edwards, C. R. W., Seckl, J. R., & Chapman, K. E. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00200-8 · Cited by 133
HAMMAMI, M. M., & SIITERI, P. K. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-326 · Cited by 124
THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MAN
WHITWORTH, J. A., STEWART, P. M., BURT, D., ATHERDEN, S. M., & EDWARDS, C. R. W. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01259.x · Cited by 110
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats
Livingstone, D., Kenyon, C., & Walker, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670533 · Cited by 87
Self-citationFriedberg, M., Zoumakis, E., Hiroi, N., Bader, T., Chrousos, G. P., & Hochberg, Z. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020510 · Cited by 75
Glucocorticoid Receptor Messenger Ribonucleic Acid in Different Regions of Human Adipose Tissue*
BRÖNNEGÅRD, M., ARNER, P., HELLSTRÖM, L., AKNER, G., & GUSTAFSSON, J.-Å. (1990) · Endocrinology · doi:10.1210/endo-127-4-1689 · Cited by 71
An in vivo study of the cortisol–cortisone shuttle in subcutaneous abdominal adipose tissue
Katz, J. R., Mohamed‐Ali, V., Wood, P. J., Yudkin, J. S., & Coppack, S. W. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00598.x · Cited by 63
11β-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., & Hochberg, Z. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020511 · Cited by 62
Abbott, W. G. H., & Foley, J. E. (1987) · Metabolism · doi:10.1016/0026-0495(87)90170-3 · Cited by 54
Handoko, K. B., Yang, K., Strutt, B. J., Khalil, W., & KILLINGER, D. W. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00029-7 · Cited by 54
Gautier, J. F., Milner, M. R., Elam, E., Chen, K., Ravussin, É., & Pratley, R. E. (1999) · Diabetologia · doi:10.1007/s001250051108 · Cited by 52
Tataranni, P. A., Cizza, G., Snitker, S., Gucciardo, F., Lotsikas, A. J., Chrousos, G. P., & Ravussin, É. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90092-6 · Cited by 28
Self-citation
Research works printed but not linked: 1
- 1985, Diabetes mellitus
Cited by
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
“Activity and mRNA abundance of the enzyme in whole adipose tissue samples are increased in obese compared with lean women and men (104, 246, 306, 325, 371, 417, 587, 588).”
BackgroundPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“More recently, several clinical studies have examined 11 -HSD1 activity in sc abdominal adipose tissue from obese men and women including a population of obese Pima Indians (140, 202, 223).”
Mechanisms of obesity-induced hypertension
Kotsis, V., Stabouli, S., Papakatsika, S., Rizos, Z., & Parati, G. (2010) · Hypertension Research · doi:10.1038/hr.2010.9 · Cited by 627
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 613
“Interestingly, hepatic 11 -HSD1 activity was reduced in obese patients in some studies, suggesting a divergent regulation of 11 -HSD1 in different tissues (121, 125).”
Background
Metadata
- Authors
- Lindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R.
- Affiliations
- National Institutes of Health (US)
- Western General Hospital (GB)
- Corresponding author
- Tataranni, P. Antonio
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2738-2744
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1978718098
- Cited by
- 225
- References
- 42
- Citations by year
- 2024: 2 · 2023: 1 · 2021: 6 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 10 · 2013: 9 · 2012: 10
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, subcutaneous adipose tissue, cortisol, cortisone, adiposity, insulin levels, insulin resistance, metabolic syndrome, obesity, Pima Indians, ethnic differences, gene expression, fasting blood glucose
- MeSH terms
- Adipose Tissue, Adult, Cortisone, Female, Humans, Hydroxysteroid Dehydrogenases, Indians, North American, Insulin, Male, Obesity, RNA, Messenger, Subcutaneous Tissue, 11-beta-Hydroxysteroid Dehydrogenase Type 1, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.